β-Blockers in Chronic Obstructive Pulmonary Disease&#x

Cardiovascular disease in chronic obstructive pulmonary disease (COPD) is common and the leading cause of death among patients with mild to moderate

Related Keywords

United States , American , Meilank Han , , Novartis , Department Of Defense , Genentech , Apreo Health , Astrazeneca , Boehringer Ingelheim , E Medical Center Dr , American Lung Association , Amgen , Acute Exacerbations , Chronic Obstructive Pulmonary Disease , Ann Arbor , Interest Disclosures , Gala Therapeutics , Aer Therapeutics ,